AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 59 filers reported holding AVROBIO INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $18,196,000 | -26.6% | 1,305,307 | -31.5% | 0.28% | -42.6% |
| Q3 2020 | $24,807,000 | -25.4% | 1,905,307 | 0.0% | 0.49% | -32.8% |
| Q2 2020 | $33,248,000 | +12.1% | 1,905,307 | 0.0% | 0.72% | -24.7% |
| Q1 2020 | $29,647,000 | +12.8% | 1,905,307 | +46.0% | 0.96% | +29.7% |
| Q4 2019 | $26,276,000 | +42.6% | 1,305,307 | 0.0% | 0.74% | +21.5% |
| Q3 2019 | $18,431,000 | +22.0% | 1,305,307 | +40.5% | 0.61% | +32.7% |
| Q2 2019 | $15,104,000 | -26.3% | 928,891 | 0.0% | 0.46% | -34.9% |
| Q1 2019 | $20,482,000 | +37.5% | 928,891 | 0.0% | 0.70% | +6.8% |
| Q4 2018 | $14,901,000 | -67.9% | 928,891 | 0.0% | 0.66% | -61.3% |
| Q3 2018 | $46,421,000 | +81.6% | 928,891 | 0.0% | 1.70% | +60.7% |
| Q2 2018 | $25,560,000 | – | 928,891 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,191,676 | $16,612,000 | 8.00% |
| Aisling Capital Management LP | 1,009,779 | $14,076,000 | 2.42% |
| Burrage Capital Management LLC | 145,715 | $2,031,000 | 1.55% |
| Camber Capital Management LP | 3,133,333 | $43,679,000 | 1.53% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $4,399,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 655,874 | $9,143,000 | 0.81% |
| EMERALD ADVISERS, LLC | 1,009,212 | $14,068,000 | 0.47% |
| Penn Mutual Asset Management, LLC | 37,306 | $520,000 | 0.46% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 932,627 | $13,001,000 | 0.45% |
| MPM BioImpact LLC | 364,285 | $5,078,000 | 0.44% |